Skyepharma Stock Price (OTCMKTS:SKYEY)

Add to My Stocks
$6.28 $0.02 (0.32%) SKYEY stock closing price Jun 24, 2016 (Closing)
Prev Close* : $6.3
Market Cap:
Day Low: $6.28
52 Week Low: $3.95
Open: $6.28
Volume: $273
Day High: $6.28
52 Week High: $6.97

Latest Stock Market News

Latest Articles

SKYEY Stockcharts

View SKYEY PE ratio, PS ratio stocks charts and compare with peers.
Note: Compare Skyepharma stock price history with the index and industry peers.

Skyepharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Skyepharma Returns

(return on equity)

Skyepharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

SKYEY Industry Peers

Company Price Change (%)
Homology Medicn (FIXX)20.010.5 (2.44%)
Cymabay (CBAY)12.230.08 (0.65%)
Horizon Pharma (HZNP)19.221.12 (5.51%)
Sanofi (SNY)43.750.06 (0.14%)
Roche Holdings (RHHBY)30.680.07 (0.23%)
Horizon Pharma (HZNP)19.221.12 (5.51%)
Astrazeneca (AZN)37.560.11 (0.29%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Progenics Pharma (PGNX)5.880.27 (4.81%)
Teva Pharmaceutical (TEVA)23.430.58 (2.54%)
BAUSCH HEALTH (BHC)22.550.2 (0.89%)
Top gainers from Medical-Generic Drugs industry
* As of Sep 18, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)19.862.02 (9.23%)
Supernus Pharma (SUPN)462.05 (4.27%)
Akorn (AKRX)13.290.44 (3.2%)
Mallinckrodt (MNK)29.670.83 (2.72%)
Corium (CORI)9.20.25 (2.65%)
Allergan (AGN)184.293.93 (2.09%)
Teligent (TLGT)3.690.05 (1.34%)
Top losers from Medical-Generic Drugs industry
* As of Sep 18, 2018

Skyepharma Financial Statements

income statement20152014201320122011
Net Sales or Revenues146.62M121.62M97.95M79.09M88.56M
Net Income40.21M-17.3M1.25M-6.97M-2.56M
Total Operating Expense32.55M30.31M25.33M27.08M34.48M
View Skyepharma income statement
balance sheet20152014201320122011
Total Assets157.78M149.97M116.73M114.91M106.37M
Total Liabilities81.49M105.14M217.82M219.53M237.45M
Shareholders Equity76.29M44.82M-101.08M-104.61M-131.07M
View Skyepharma balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) in Assets Liabilities-14.37M4.94M-3.91M--2.72M
Net Cash from (used by) Operating Activities38.52M49.27M22.22M29M19.73M
Increase (Decrease) in Prop Plant And Equipment-5.35M-1.81M-3.59M-0.79M-3.85M
View Skyepharma cash flow statement

Skyepharma Stock Message Board

Skyepharma stock lost 0.32%, and the last close price as of Jun 24, 2016 is $6.28 for SKYEY stock. Looking at Skyepharma market capitalization, which currently stands at $658.22M, we can say that SKYEY stock is a Small Cap stock. Skyepharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Skyepharma stock price and Skyepharma share price mean the same thing. The volume of shares traded stood at 273 on the last trading day, as is evident from Skyepharma stock chart, and SKYEY stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Skyepharma stock dividend was 0.00 during the last quarter. Skyepharma stock price history, gives the entire historical data for SKYEY stock.